We are live on ! Find out more
SCM

Suvretta Capital Management Portfolio holdings

AUM $3.92B
1-Year Est. Return 86.67%
This Fund
S&P 500
This Quarter Est. Return
-5.34%
1 Year Est. Return
+86.67%
3 Year Est. Return
+295.96%
5 Year Est. Return
+364.48%
10 Year Est. Return
+2,073.65%
AUM
$3.27B
AUM Growth
-$1.89B
Cap. Flow
-$1.48B
Cap. Flow %
-45.31%
Top 10 Hldgs %
36.77%
Holding
111
New
16
Increased
19
Reduced
19
Closed
24

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$98.2M
2
V icon
Visa
V
+$94.7M
3
LVS icon
Las Vegas Sands
LVS
+$94.4M
4
SCHW
Charles Schwab
SCHW
+$86.5M
5
SPGI icon
S&P Global
SPGI
+$84.2M

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$222M
2
AMZN icon
Amazon
AMZN
+$194M
3
ADI icon
Analog Devices
ADI
+$144M
4
PWR icon
Quanta Services
PWR
+$133M
5
COR icon
Cencora
COR
+$122M

Sector Composition

Rank Sector Weight
1 Healthcare 47.04%
2 Consumer Discretionary 18.58%
3 Financials 10.68%
4 Industrials 10.44%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.84T
$184M 5.61%
595,747
-269,253
-31% -$81M
UNP icon
2
Union Pacific
UNP
$183B
$168M 5.12%
613,628
-194,392
-24% -$49.1M
AMZN icon
3
Amazon
AMZN
$2.5T
$147M 4.49%
902,440
-1,258,160
-58% -$194M
UNH icon
4
UnitedHealth
UNH
$382B
$123M 3.75%
240,997
-215,793
-47% -$104M
EL icon
5
Estee Lauder
EL
$29B
$101M 3.1%
372,475
-76,885
-17% -$23.1M
CNC icon
6
Centene
CNC
$31.3B
$101M 3.08%
+1,197,206
New +$98.2M
OTIS icon
7
Otis Worldwide
OTIS
$27.4B
$99.8M 3.05%
1,297,480
-1,187,100
-48% -$94.9M
V icon
8
Visa
V
$677B
$97.1M 2.97%
+437,990
New +$94.7M
ITCI
9
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$93.7M 2.86%
1,531,923
+279,977
+22% +$14.5M
IQV icon
10
IQVIA
IQV
$34.7B
$89.4M 2.73%
386,710
-173,050
-31% -$41M
LVS icon
11
Las Vegas Sands
LVS
$30.5B
$88.4M 2.7%
+2,275,282
New +$94.4M
TPR icon
12
Tapestry
TPR
$28.8B
$86.2M 2.63%
2,320,100
-2,227,360
-49% -$85.3M
SPGI icon
13
S&P Global
SPGI
$126B
$84.8M 2.59%
+206,760
New +$84.2M
SCHW
14
Charles Schwab
SCHW
$177B
$82.9M 2.53%
+982,790
New +$86.5M
HUM icon
15
Humana
HUM
$46.7B
$82.2M 2.51%
+188,888
New +$79M
RPRX icon
16
Royalty Pharma
RPRX
$26.1B
$78.9M 2.41%
2,025,610
+58,337
+3% +$2.29M
GFL icon
17
GFL Environmental
GFL
$14.3B
$74.3M 2.27%
2,284,496
-2,342,544
-51% -$73.4M
JNJ icon
18
Johnson & Johnson
JNJ
$635B
$73.6M 2.25%
+415,310
New +$70.7M
MA icon
19
Mastercard
MA
$477B
$68.2M 2.08%
190,943
-59,327
-24% -$21.3M
DHR icon
20
Danaher
DHR
$135B
$68.2M 2.08%
262,339
+13,953
+6% +$3.49M
TMO icon
21
Thermo Fisher Scientific
TMO
$211B
$68M 2.08%
115,069
-155,401
-57% -$89.3M
KURA icon
22
Kura Oncology
KURA
$922M
$62.6M 1.91%
3,893,019
+320,600
+9% +$4.63M
FULC icon
23
Fulcrum Therapeutics
FULC
$248M
$61.8M 1.89%
2,613,412
+237,841
+10% +$3.37M
RH icon
24
RH
RH
$3.3B
$59.3M 1.81%
181,835
-68,085
-27% -$27.2M
COR icon
25
Cencora
COR
$60.3B
$59.3M 1.81%
383,138
-860,672
-69% -$122M
1
2 3 4 5

Similar funds

MIM
Meridiem Investment Management London, United Kingdom $3.92B AUM 1.64% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $3.92B AUM 15.21% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
MSI
Mitsui Sumitomo Insurance Tokyo, Japan $3.9B AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return

Suvretta Capital Management's Q1 2022 Portfolio in Review

As of Q1 2022, Suvretta Capital Management held 111 positions worth $3.27B, down 37% from $5.16B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Suvretta Capital Management withdrew a net $1.48B in Q1 2022, closing 24 positions and reducing 19 holdings. Its most notable exit was Adobe, an estimated $222M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Suvretta Capital Management opened a new position in Centene worth $101M.

  • Suvretta Capital Management's largest Q1 2022 buy was Centene: 1,197,206 shares worth $101M.
  • Suvretta Capital Management added most to Marqeta in Q1 2022, an estimated $30M increase.
  • Suvretta Capital Management's biggest Q1 2022 reduction was Amazon, cutting an estimated $194M.
  • Suvretta Capital Management fully exited Adobe in Q1 2022, selling an estimated $222M.
  • Suvretta Capital Management's ten largest holdings make up 37% of its $3.27B portfolio in Q1 2022.
  • Suvretta Capital Management opened 16 new positions and closed 24 in Q1 2022.
  • Suvretta Capital Management's portfolio value fell 37% quarter-over-quarter to $3.27B.

Based on Suvretta Capital Management's 13F filing for Q1 2022, filed 16 May 2022.